SGLT-2 Inhibitors Reduce Dementia Risk vs DPP-4 Inhibitors ...Middle East

Medscape - News
In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing the risk for dementia and Alzheimer's disease. Medscape Medical News

Hence then, the article about sglt 2 inhibitors reduce dementia risk vs dpp 4 inhibitors was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SGLT-2 Inhibitors Reduce Dementia Risk vs DPP-4 Inhibitors )

Apple Storegoogle play

Last updated :

Also on site :



Latest News